Mariana Oncology

Biotech · Acquired

Precision radiopharmaceuticals for cancer treatment

marianaoncology.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
31
0 granted · 31 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1126Inhibrx, Inc.—$669M
1127Odyssey Therapeutics—$571M
1128Moderna—$556M
1129Mariana Oncology——
1130OMVAX, INC.——
1131Denali Therapeutics—$500M
1132MS Biotech Holdings, Inc.—$59M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 31
  • B7-H3 Targeting Peptides And Constructs Thereofapplication
  • Enriched And Stable Radioligand Therapy Formulations And Pharmaceutical Compositions Comprising Sameapplication
  • DLL3 Targeting Peptides And Constructs Thereofapplication
  • DLL3 Targeting Peptides And Constructs Thereofapplication
  • DLL3 Targeting Peptides And Constructs Thereofapplication
  • DLL3 Targeting Peptides And Constructs Thereofapplication
  • DLL3 Targeting Peptides And Constructs Thereofapplication
  • DLL3 Targeting Peptides And Constructs Thereofapplication
  • DLL3 Targeting Peptides And Constructs Thereofapplication
  • DLL3 Targeting Peptides And Constructs Thereofapplication
  • DLL3 Targeted Constructsapplication
  • DLL3 Targeted Constructsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.